Kraig Biocraft Laboratories, Inc.
KBLB
$0.09
$0.002.82%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -248.48% | 54.79% | -18.13% | 35.70% | 21.14% |
| Total Depreciation and Amortization | 225.76% | 450.75% | -14.93% | -28.78% | -9.59% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,542.24% | -99.49% | 34.99% | -91.55% | -177.30% |
| Change in Net Operating Assets | -5.41% | 19.24% | 113.99% | -19.34% | -25.09% |
| Cash from Operations | -41.56% | 13.25% | 11.24% | -56.39% | -31.20% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -861.54% | -- | -- | 100.00% | 65.33% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 19,701.92% | 4,687.33% | 1,154.67% | 100.00% | 65.33% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 335.35% | 173.89% | 45.23% | -50.80% | -122.74% |